BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12357502)

  • 1. Endometrial cells and the AutoPap System for primary screening of cervicovaginal Pap smears.
    Walts AE; Thomas P
    Diagn Cytopathol; 2002 Oct; 27(4):232-7. PubMed ID: 12357502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
    Wertlake P
    J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of a computerised system in the reading of cytological cervicovaginals smears during programming of regional screening (one year of experience using the autopap system)].
    Orlassino R; Fabbrini T; Gallo C; Vineis C
    Pathologica; 2005 Apr; 97(2):78-83. PubMed ID: 16032952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women.
    Chang A; Sandweiss L; Bose S
    Gynecol Oncol; 2001 Jan; 80(1):37-43. PubMed ID: 11136567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of AutoPap system location-guided screening in the evaluation of cervical cytology smears.
    Stevens MW; Milne AJ; Parkinson IH; Nespolon WW; Fazzalari NL; Arora N; Dodd TJ
    Diagn Cytopathol; 2004 Aug; 31(2):94-9. PubMed ID: 15282720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
    Marshall CJ; Rowe L; Bentz JS
    Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the AutoPap (currently Focalpoint) primary screening system location guide use on interpretation time and diagnosis.
    Ronco G; Vineis C; Montanari G; Orlassino R; Parisio F; Arnaud S; Berardengo E; Fabbrini T; Segnan N
    Cancer; 2003 Apr; 99(2):83-8. PubMed ID: 12704687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Djemli A; Khetani K; Auger M
    Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial metaplasia as a source of atypical glandular cells in cervicovaginal smears.
    Johnson TL; Kini SR
    Diagn Cytopathol; 1996 Feb; 14(1):25-31. PubMed ID: 8834073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study.
    Schorge JO; Hossein Saboorian M; Hynan L; Ashfaq R
    Cancer; 2002 Dec; 96(6):338-43. PubMed ID: 12478681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of a cytologic diagnosis of atypical glandular cells, favor endometrial origin, in Pap smears.
    Saad RS; Takei H; Liu YL; Silverman JE; Lipscomb JT; Ruiz B
    Acta Cytol; 2006; 50(1):48-54. PubMed ID: 16514840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical trial of the AutoPap 300 QC system for quality control of cervicovaginal cytology in the clinical laboratory.
    Colgan TJ; Patten SF; Lee JS
    Acta Cytol; 1995; 39(6):1191-8. PubMed ID: 7483997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the financial impact of covering new screening technologies. The case of automated Pap smears.
    McQuarrie HG; Ogden J; Costa M
    J Reprod Med; 2000 Nov; 45(11):898-906. PubMed ID: 11127101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does use of the AutoPap assisted primary screener improve cytologic diagnosis?
    Bibbo M; Hawthorne C; Zimmerman B
    Acta Cytol; 1999; 43(1):23-6. PubMed ID: 9987445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feasibility study of the AutoPap system location-guided screening.
    Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
    Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening device.
    Confortini M; Bonardi L; Bulgaresi P; Cariaggi MP; Cecchini S; Ciatto S; Cipparrone I; Galanti L; Maddau C; Matucci M; Rubeca T; Troni GM; Turco P; Zappa M; Carozzi F
    Cancer; 2003 Jun; 99(3):129-34. PubMed ID: 12811852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degenerative necrotic endometrial debris in Papanicolaou smears. The role in the prediction of endometrial pathology.
    Lai CR; Hsu CY; Li AF
    Am J Clin Pathol; 2012 Feb; 137(2):290-4. PubMed ID: 22261456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of atypical endometrial cells detected by cervical cytology.
    Cherkis RC; Patten SF; Dickinson JC; Dekanich AS
    Obstet Gynecol; 1987 May; 69(5):786-9. PubMed ID: 3574808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial carcinoma detected with SurePath liquid-based cervical cytology: comparison with conventional cytology.
    Patel C; Ullal A; Roberts M; Brady J; Birch P; Bulmer JN; Wadehra V
    Cytopathology; 2009 Dec; 20(6):380-7. PubMed ID: 19207308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the AutoPap Primary Screening System in the detection of high-risk cases in cervicovaginal smears.
    Alasio LM; Alphandery C; Grassi P; Ruggeri M; De Palo G; Pilotti S
    Acta Cytol; 2001; 45(5):704-8. PubMed ID: 11575647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.